Page 13 - Mayo Clinic Graduate School News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Purified exosomal product accelerates wound healing in preclinical models Difficult-to-treat, chronic wounds in preclinical models healed with normal scar-free skin after treatment with an acellular product discovered at Mayo Clinic. Derived from platelets, the purified exosomal product, known as PEP, was used to deliver healing messages into cells of preclinical animal models of ischemic wounds. The Mayo Clinic research team documented restoration of skin integrity, hair follicles, sweat glands, skin oils and normal hydration. Ischemic wounds occur when arteries are clogged or blocked, preventing important nutrients and oxygen from reaching the skin to drive repair. This groundbreaking study titled, TGF-β Donor Exosome Accelerates Ischemic Wound Healing, is published in

Atta behfarSteven moranEmily hendersonDrug administrationMayo clinic centerMayo clinicDonor exosome accelerates ischemic wound healingRegenerative medicineNational institutesRegenerative sciences training programMayo clinic graduate schoolBiomedical sciencesஅட்டா பெஹபார்ஸ்டீவன் மோரன்எமிலி ஹென்டர்சன்மயோ சிகிச்சையகம் மையம்